Charles River Laboratories International (CRL) Income towards Parent Company: 2009-2025
Historic Income towards Parent Company for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $55.6 million.
- Charles River Laboratories International's Income towards Parent Company fell 20.97% to $55.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$79.6 million, marking a year-over-year decrease of 118.60%. This contributed to the annual value of $25.3 million for FY2024, which is 94.74% down from last year.
- According to the latest figures from Q3 2025, Charles River Laboratories International's Income towards Parent Company is $55.6 million, which was up 5.43% from $52.7 million recorded in Q2 2025.
- Charles River Laboratories International's 5-year Income towards Parent Company high stood at $189.1 million for Q4 2022, and its period low was -$213.7 million during Q4 2024.
- Moreover, its 3-year median value for Income towards Parent Company was $74.5 million (2024), whereas its average is $58.2 million.
- In the last 5 years, Charles River Laboratories International's Income towards Parent Company skyrocketed by 48.94% in 2022 and then slumped by 213.12% in 2024.
- Quarterly analysis of 5 years shows Charles River Laboratories International's Income towards Parent Company stood at $139.8 million in 2021, then skyrocketed by 35.24% to $189.1 million in 2022, then declined by 0.08% to $189.0 million in 2023, then slumped by 213.12% to -$213.7 million in 2024, then decreased by 20.97% to $55.6 million in 2025.
- Its Income towards Parent Company was $55.6 million in Q3 2025, compared to $52.7 million in Q2 2025 and $25.9 million in Q1 2025.